Michael Way did his undergraduate in the Biophysics Dept. King’s College, London. During his Ph.D. he studied the actin binding properties of gelsolin in the lab of Alan Weeds in the structural studies division of the Medical Research Council, Laboratory of Molecular Biology, Cambridge, UK. In 1989 he received the Max Perutz student prize for his Ph.D. work. He remained in Alan’s lab as a postdoc for three years studying the actin binding properties of alpha-actinin, dystrophin and gelsolin before moving to Boston, for a second postdoc with Paul Matsudaira at the Whitehead Institute, MIT, USA. In 1995, he started his own group in the Cell Biology Programme at the European Molecular Biology Laboratory (EMBL), Heidelberg, Germany, studying how vaccinia virus hijacks the actin cytoskeleton to enhance its spread. In 2001, Michael returned to London to head the cell motility group in the London Research Institute, Cancer Research UK. In 2016 he moved to the Francis Crick Institute to lead the Cellular Signalling and Cytoskeletal Function Lab.
Michael has been an editor for the Journal of Cell Science since 2005 and was appointed its editor-in-chief in 2012. He is on the editorial boards of Cellular Microbiology, Cell Host & Microbe, Developmental Cell, EMBO Journal, EMBO Reports and Small GTPases. He was elected an EMBO member in 2006 and a fellow of the Academy of Medical Sciences in 2015. Michael is an honorary Professor at University College, London as well as King’s College, London and is a Professor of Virology, Imperial College, London since 2013.